14 April 2025 in Clinical Nuclear Medicine
Prostate-specific membrane antigen (PSMA) is a specific marker of the prostate cell lineage. 68Ga-PSMA PET/CT is a sensitive and valuable imaging modality used for staging at diagnosis and restaging in cases of recurrence during the follow-up of prostate carcinoma patients. However, increased PSMA uptake can be observed in various malignancies, such as cholangiocarcinoma, hepatocellular carcinoma, adenoid cystic carcinoma, renal cell carcinoma, and in several benign conditions, such as angiolipoma. Here, we present a case of a newly diagnosed prostate carcinoma patient with a schwannoma exhibiting intense 68Ga PSMA uptake mimicking paravertebral soft tissue metastasis of prostate cancer.
27 May 2025 in Clinical Nuclear Medicine
Purpose: To evaluate the potential of integrated multiparametric 68Ga DOTATATE PET/MR imaging for assessing liver lesions of well-differentiated neuroendocrine tumors (NETs) and to identify imaging parameters predictive of primary tumor localization. Patients and Methods: This retrospective study involves patients with well-differentiated NETs who underwent 68Ga DOTATATE PET/MRI between September 2018 and November 2024. Inclusion criteria required histopathologically proven NETs with 68Ga DOTATATE-avid liver metastases and complete multiparametric MRI sequences. PET and MRI-derived variables, including SUVmax, ADCmin, T/L ratios, and tumor volume (log-transformed tumor volume: LOGVOL), were analyzed. Linear mixed-effects models and logistic regression analyses were performed to identify relationships between imaging features and tumor characteristics. ROC analyses were conducted to evaluate the accuracy of primary tumor origin predictions. Results: Of 43 imaging sessions, 14 patients (7 male, 7 female; median age 59 y) with 181 lesions met the inclusion criteria. SUVmax was significantly correlated with LOGVOL and contrast enhancement parameters (eg, WOliver). Linear mixed-effects models revealed that LOGVOL and WOliver were independent predictors of SUVmax. In the binomial regression analysis, tumor precontrast T1 intensity, T/Lart, and T/Lven were significant factors in differentiation between pancreatic and gastrointestinal (GIS) NET metastases, with pancreatic tumors demonstrating higher T/Lart and GIS tumors exhibiting higher T/Lven and T1 intensity. Logistic regression achieved an AUC of 0.911, with a sensitivity of 86% and specificity of 76%. Conclusion: 68Ga DOTATATE PET/MRI effectively integrates metabolic and anatomical imaging for characterizing NET liver metastases. Parameters such as LOGVOL and WOliver independently predict SUVmax, while precontrast T1 intensity, T/Lart, and T/Lven assist in differentiating pancreatic from GIS NETs. These findings underscore the potential of 68Ga DOTATATE PET/MRI in personalized NET management and suggest avenues for further research to confirm these results.
29 April 2025 in Clinical Nuclear Medicine
Plastron appendicitis is a rare complication of acute appendicitis, characterized by localized and encapsulated inflammation within the surrounding tissues. It accounts for ∼4%–5% of all acute appendicitis cases. The mass-like appearance of plastron appendicitis can mimic various malignant pathologies, particularly those of the adnexal region. Due to its rarity, diagnosing plastron appendicitis can be challenging. Advanced imaging techniques, such as 18 F-FDG PET/CT, are crucial in differentiating it from other pathologies. In this case presentation, we aim to present the 18 F-FDG PET/CT and contrast-enhanced CT imaging findings of a patient with plastron appendicitis, which was initially suspected to be a malignant adnexal mass.
26 August 2022 in Nuclear Medicine Seminars
27 July 2026 in Nuklearmedizin-Nuclear Medicine
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor that may express somatostatin receptors, enabling imaging with ⁶⁸Ga-DOTATATE PET/CT. Brain metastases from MTC are extremely rare, particularly in the absence of an identifiable primary tumor. We present a 63-year-old male with occult MTC and elevated serum calcitonin levels (27 pg/mL). ⁶⁸Ga-DOTATATE PET/CT demonstrated focal tracer uptake in the right parietal lobe (SUVmax: 9.1), which was confirmed by brain MRI as a 7-mm enhancing lesion consistent with metastasis. This case highlights the value of ⁶⁸Ga-DOTATATE PET/CT in detecting unusual metastatic presentations in occult MTC.
17 July 2024 in Molecular Imaging and Radionuclide Therapy
Objectives: The aim of this study was to evaluate the prognostic value of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/ computed tomography (PET/CT) in the uterine cervix cancer patients. Methods: Thirty-two women (mean age: 52.7 +/- 12.6) who underwent 18F-FDG PET/CT for staging of uterine cervix cancer were retrospectively recruited for the study. Maximum standardized uptake value (SUVmax), SUVmean, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) for primary tumors, lymph nodes, and distant metastases were calculated from 18F-FDG PET/CT images using the 40% threshold. Patients were divided into groups according to the presence of pelvic and para-aortic lymph node involvement on 18F-FDG PET/CT images. Life tables and KaplanMeier analyses were performed to compare the mean survival times of the different groups. Results: Primary tumor of 27 (84%) patients were 18F-FDG avid. The median SUVmax, SUVmean, MTV, and TLG of the primary tumors were 12.4, 6.1, 13.2 cm3 and 87.8 g/mL x cm3 respectively. Pathological uptake was detected in pelvic 14 (44%) patients and in paraaortic lymph nodes in 3 (10%) para-aortic lymph nodes. The median whole-body MTV and TLG were 21.7 cm3 and 91.1 g/mL x cm3. Disease progression was detected in 7 (22%) patients within a median follow-up period of 20.9 (minimum-maximum: 3-82) months. The only significant PET parameter to predict progression-free survival was SUVmax in the primary tumor (p=0.038). During follow-up period 8 patients died. SUVmax (p=0.007), MTV (p=0.036), TLG (p=0.001) of primary tumor, presence of pathological uptake on pelvic or paraaortic lymph nodes (p=0.015), whole-body MTV (p=0.047) and whole-body TLG (p=0.001) were found statistically significant PET parameters to predict overall survival. Conclusion: Metabolic parameters of primary tumors derived from 18F-FDG PET/CT images have prognostic importance for patients with uterine cervical carcinoma. In patients with metastatic disease, higher whole-body MTV and TLG are also associated with poor prognosis.